HK1255895A1 - 用於抑制內毒素進入血液的組合物 - Google Patents

用於抑制內毒素進入血液的組合物

Info

Publication number
HK1255895A1
HK1255895A1 HK18114979.6A HK18114979A HK1255895A1 HK 1255895 A1 HK1255895 A1 HK 1255895A1 HK 18114979 A HK18114979 A HK 18114979A HK 1255895 A1 HK1255895 A1 HK 1255895A1
Authority
HK
Hong Kong
Prior art keywords
endotoxin
blood
composition
inhibiting migration
migration
Prior art date
Application number
HK18114979.6A
Other languages
English (en)
Inventor
Hisae Kume
Keiko Okazaki
Kinya Ashida
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of HK1255895A1 publication Critical patent/HK1255895A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK18114979.6A 2016-01-22 2018-11-22 用於抑制內毒素進入血液的組合物 HK1255895A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016010840 2016-01-22
PCT/JP2017/001856 WO2017126645A1 (ja) 2016-01-22 2017-01-20 エンドトキシンの血中移行阻害用組成物

Publications (1)

Publication Number Publication Date
HK1255895A1 true HK1255895A1 (zh) 2019-08-30

Family

ID=59362471

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114979.6A HK1255895A1 (zh) 2016-01-22 2018-11-22 用於抑制內毒素進入血液的組合物

Country Status (6)

Country Link
JP (1) JP7383874B2 (zh)
CN (1) CN108472331A (zh)
HK (1) HK1255895A1 (zh)
SG (1) SG11201805957QA (zh)
TW (1) TW201735942A (zh)
WO (1) WO2017126645A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023106078A1 (zh) * 2021-12-10 2023-06-15

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008033A1 (de) * 1990-03-14 1991-09-19 Nitsche Dietrich Verwendung von lactoferrin zur bekaempfung der toxischen wirkung des endotoxins
JPH07278013A (ja) * 1994-03-31 1995-10-24 Snow Brand Milk Prod Co Ltd エンドトキシン中和剤
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
JP4672163B2 (ja) 2000-03-24 2011-04-20 明治乳業株式会社 グラム陰性菌のリピドａに対する特異的抗体産生を誘導する組成物。
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
WO2011065552A1 (ja) * 2009-11-30 2011-06-03 明治乳業株式会社 小腸に良い栄養組成物
JP6234227B2 (ja) * 2011-11-30 2017-11-22 株式会社明治 腸内菌叢改善用栄養組成物
JP5501416B2 (ja) 2012-08-08 2014-05-21 本田技研工業株式会社 鞍乗型車両の変速機冷却ダクト

Also Published As

Publication number Publication date
SG11201805957QA (en) 2018-08-30
JPWO2017126645A1 (ja) 2018-11-08
TW201735942A (zh) 2017-10-16
WO2017126645A1 (ja) 2017-07-27
JP7383874B2 (ja) 2023-11-21
CN108472331A (zh) 2018-08-31

Similar Documents

Publication Publication Date Title
HK1245247A1 (zh) 溴結構域的抑制劑
IL254518A0 (en) Preparations and methods for suppressing the expression of the factor xii gene
HK1258062A1 (zh) 給予惡拉戈利的方法
HUE056172T2 (hu) Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra
HK1252852A1 (zh) 阻止HIF2α基因表達的組合物及方法
IL257061A (en) Inhibitors of ezh2
PL3349743T3 (pl) Sposoby i kompozycje do hamowania oddziaływania dcn1-ubc12
HK1257689A1 (zh) 使過氧化物酶體增殖物激活受體共激活因子1-α的表達增加的組合物
IL259856A (en) A preparation for the treatment of Crigler-Najjar syndrome
GB2555968B (en) Controlled activation of extended-life cement compositions
HK1255221A1 (zh) 使用卡多曲組合物進行治療的方法
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
PT3283097T (pt) Fsh para tratamento de infertilidade
HK1252057A1 (zh) 新穎的使用方法和組合物
HK1258438A1 (zh) 2-巰基苯並噻唑的製備方法
GB2539420B (en) Determination of chromatography conditions
HK1255895A1 (zh) 用於抑制內毒素進入血液的組合物
GB2558700B (en) 4-substituted Analogs of Cytisine
IL247645A0 (en) Preparations of seleno-organic compounds and methods of using them
GB201513188D0 (en) Method of tomography
TWM490285U (en) Descending stopper of curtain set
TWM490377U (en) Improved structure of C clamp
PT3335729T (pt) Composição de etanercept com estabilidade melhorada
GB201502834D0 (en) Composition of objects
GB201508443D0 (en) Methods of identifying USP-binding compounds